Peri-operative Therapy in Thoracic Cancer
The course presents a review of recent changes in the management of resected NSCLC as well as the management of patients with early stage NSCLC treated with SBRT. The four main topics are:
Category
  • Lung Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Stage III Thoracic Cancer Debates
The course consists of two debates. The first debate consists of two thoracic oncologists with one arguing for the use of surgery and one against the use of surgery for patients with stage III NSCLC.
Category
  • Lung Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Management of a Tonsil Cancer Patient: From Work-up through Late Radiation Toxicity - 2021 Annual Meeting
This course guides the audience through a very practical approach to work up and management of an HPV+ tonsil cancer patient (T1N1), from initial examination and work-up through late complications.
Category
  • Head and Neck Cancer
Format
  • Online SA-CME
Credits
  • 1.00 Certificate of Attendance
  • 1.00 SA-CME
Thoracic Cancer Beyond the Clinic - Community Impacts
Covid-19 rapidly affected our lives and the life of our patients. Vaccination campaign started in 2021. At least four types of vaccines are widely used in the US (Pfizer, Moderna, Johnson and Johnson and Astra Zeneca).
Category
  • Lung Cancer
Format
  • CME only
Credits
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Certificate of Attendance
Patient Focused Treatment of Gynecologic Cancers - 2021 Annual Meeting
This panel of speakers examine four different aspects of patient oriented factors that will allow the practicing radiation oncologist to better recommend, direct, and evaluate the results of therapy for women with gynecologic cancers.
Category
  • Gynecologic Cancer
Format
  • Online SA-CME
Credits
  • 1.25 Certificate of Attendance
  • 1.25 SA-CME
ASTRO’s First Evidence-Based Clinical Practice Guidelines on Radiation Therapy for Primary Liver Cancers - 2021 Annual Meeting
This cased-based panel focuses on the guideline recommendations and evidentiary basis for EBRT for HCC and IHC.
Category
  • Gastrointestinal Cancer
Format
  • Online SA-CME
Credits
  • 1.25 Certificate of Attendance
  • 1.25 SA-CME
Debating the Best Treatment for Early Prostate Cancer: Surgery, Radiation, or Neither - 2021 Annual Meeting
This course involves a case-based discussion with a panel of experts to review the various treatment options for early stage prostate cancer, including active surveillance, radical prostatectomy, external beam radiotherapy (including intensity modulated radiation therapy and stereotactic body rad
Category
  • Genitourinary Cancer
Format
  • Online SA-CME
Credits
  • 1.00 Certificate of Attendance
  • 1.00 SA-CME
2022 ASTRO Annual Refresher Course onDemand
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology, including sarcomas, pediatrics and the role of radiotherapy in the multidisciplinary management of c
Category
  • Non Clinical Skills
  • SBRT
  • Breast Cancer
  • Radiobiology
  • Sarcoma/Cutaneous
  • Central Nervous System
  • Lung Cancer
  • Leuk/Lymph/Hema
  • Pediatric Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
Format
  • OnDemand Meeting
Credits
  • 18.00 AMA PRA Category 1 Credit™
  • 18.00 Certificate of Attendance
A Systematic Review Into the Radiological Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients with Non-small Cell Lung Cancer (NSCLC)
This journal activity provides practitioners with the knowledge needed to better interpret imaging studies performed following lung SBRT and what features should lead to concern for local recurrence.
Category
  • Lung Cancer
Format
  • Journal SA-CME
Credits
  • 1.00 Certificate of Attendance
  • 1.00 SA-CME
Lung - Refresher 2022
Major decreases in cancer mortality have been driven by improvements in the management of lung cancer. The explanation for these survival improvements is complex but largely driven by the increasing use of systemic therapies in early stage disease such as immunotherapy.
Category
  • Lung Cancer
Format
  • Online SA-CME
Credits
  • 1.50 Certificate of Attendance
  • 1.50 SA-CME

Pages